Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

Item
http://www.wikidata.org/entity/Q43823409
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitusDeletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet.Atherosclerosis in chronic kidney disease: the role of macrophagesLong-term clinical experience with zofenopril.MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.Zofenopril attenuates injury induced by ischemia-reperfusion on rat ovary.Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
P2860

Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

Item
http://www.wikidata.org/entity/Q43823409
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
type
label
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
prefLabel
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@en
Chronic treatment with sulfhyd ...... polipoprotein E knockout mice.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Chronic treatment with sulfhyd ...... apolipoprotein E knockout mice
@en
P2093
P304
P31
P356
10.1016/S0167-5273(01)00542-3
P407
P433
P478
P50
P577
P698
P921